Background {#Sec1}
==========

Schistosomiasis, caused by blood-dwelling flukes, is one of the most prevalent parasitic diseases with over 200 million people infected, nearly 800 million people threatened and 70 million disability-adjusted life-years lost worldwide \[[@CR1]\]. In China where *Schistosoma japonicum* was once highly endemic, after nearly 70 years of control a great progress has been made \[[@CR2]\]. For example, the number of infected people had declined from 11.6 million in the mid-1950s to nearly 77.2 thousand in 2015 \[[@CR3], [@CR4]\]. By the end of 2015, out of 453 endemic counties (city, district), 343 and 110 had achieved criteria of transmission interruption and of transmission control, respectively. The overall objective of the Mid- and Long-term National Plan for Prevention and Control of Schistosomiasis of China (2004--2015) has been achieved on schedule \[[@CR5]\]. Based on above achievements, therefore, a new goal-to interrupt transmission by 2020 and then to completely eliminate the disease across China by 2025-for the next 10 years was proposed in 2015 \[[@CR6]\]. However, due to the complex lifecycle of *Schistosoma japonicum* and many natural and social factors in affecting the transmission and spread of schistosomiasis, schistosomiasis elimination still faces serious challenges. In addition, no effective vaccine is available and praziquantel is the only recommended drug by WHO for the treatment of schistosomiasis \[[@CR7], [@CR8]\]. Therefore, accurately assessing the real prevalence of *Schistosoma japonicum* infections in humans through simple and sensitive diagnostic tests is very essential in China \[[@CR9]\].

There are currently various diagnostics for *S. japonicum* infection in humans, including direct parasitological tests, immunological techniques and molecular diagnosis \[[@CR10]\]. Direct parasitological tests, such as the Kato-Katz thick smear technique (Kato-Katz or KK), are the earliest diagnosis used for identification of schistosomiasis and are still widely applied nowadays \[[@CR11]\]. However, with the continual decrease of the prevalence and intensity of *S. japonicum* infection, parasitological tests are not sensitive and accurate enough to estimate the real prevalence, especially in low endemic regions \[[@CR12]--[@CR14]\]. Immunological techniques, including the indirect hemagglutination assay (IHA) and the enzyme-linked immunosorbent assay (ELISA), have become more popular in schistosome detection as they are more sensitive, rapid and easy to perform \[[@CR15], [@CR16]\]. A number of studies have been conducted to evaluate the effectiveness of different diagnostic assays either in the laboratory or in the field. However, the different or controversial results were among these findings. A meta-analysis on the immunodiagnostic efficacies of IHA and ELISA in field settings performed by Wang et al. \[[@CR17]\] revealed that IHA is superior to ELISA, but the research by Wang et al. \[[@CR18]\] showed that ELISA is better than IHA. Three other meta-analyses \[[@CR19]--[@CR21]\] were used to assess the accuracy of IHA, ELISA and the dipstick dye immunoassay (DDIA), respectively. All the above articles were mainly aimed at immunological tests. However, comparisons between parasitological and immunological examinations of the same village-based subjects in the field of China have not yet been conducted. The neglect of egg-negative but worm-positive schistosomiasis, especially in low endemic areas, may influence control effects and thus hinder the elimination of schistosomiasis \[[@CR22]\]. Therefore, we performed this meta-analysis to compare the seroprevalence of *Schistosoma japonicum*, as determined by IHA or ELISA, with coprological prevalence, as assessed using Kato-Katz, and estimate the ratio of the serological to the egg-positive prevalence. The main purpose was to evaluate the potential threat of egg-negative but worm-positive schistosomiasis.

Methods {#Sec2}
=======

Study protocol and registration {#Sec3}
-------------------------------

The protocol for this study was developed prospectively and registered in the international Prospective Register of Systemic Reviews (PROSPERO) online database (<https://www.crd.york.ac.uk/PROSPERO>, with registered number CRD42017067941) on June 6, 2017. The protocol is provided as Supporting Information (see Additional file [1](#MOESM1){ref-type="media"}).

Search strategy {#Sec4}
---------------

A database search through July 2018 was performed to identify relevant studies regarding the comparison between seroprevalence of *S. japonicum* determined by IHA or ELISA and coprological prevalence with Kato-Katz. We aimed to include all published studies in Chinese or English. Three Chinese literature databases, including China National Knowledge Infrastructure (CNKI), WanFang Database and Chinese Scientific Journal Database (VIP), and two English literature databases, including PubMed and Web of Science, were searched for data pertaining to the prevalence rate of *S. japonicum* determined by three diagnostic tests in field surveys in China. We used the following search terms (the corresponding Chinese keyword in Pinyin (phoneticism) was given between brackets): "*schistosoma*", "schistosomiasis", "bilharzia", "bilharziasis" (xuexichong) in combination with "Kato" and "IHA" or "ELISA". We did not contact authors of original studies for additional information. No attempt was made to identify unpublished studies.

Study selection {#Sec5}
---------------

An initial screen of identified titles and abstracts was performed by YD and CQ. A second screen of full-text articles was then conducted if the studies were found suitable for inclusion. Studies to qualify the following criteria were included: (1) field surveys; (2) targeted subjects included residents from endemic villages, and received both a fecal examination with Kato-Katz and a serological examination with IHA or ELISA, simultaneously; (3) a survey in one village, or more villages of the same endemic level, could be taken as a study; (4) one stool sample from each participant was provided; (5) data on numbers of the positive and the total examined were provided, or could be obtained by formula. Studies to exclude were: (1) about animals or from laboratories; (2) in the same village and repeated periods; (3) no eggs found in a stool specimen; (4) about floating populations, such as fishermen and boatmen; (5) full texts unavailable.

Data extraction and quality assessment {#Sec6}
--------------------------------------

The detailed features of each eligible study were extracted using a purpose-built data-collection excel form. Information was recorded as follows: study characteristics (last name of the first author, year of publication, period of study, location); characteristics of targeted villages (the recorded prevalence level and the type of endemic area); study methodology (the fecal and serological examinations used); numbers of the positive and the total of persons assessed. Information about the endemic level or type of the targeted villages was extracted from relevant articles if such data were not provided in the eligible studies.

Bias in data collection was reduced through the involvement of YD and CQ, who independently evaluated the quality of studies. In cases of disagreement, HD was consulted in order to resolve the problem.

Data analyses {#Sec7}
-------------

The ratio of the serological to the egg-positive prevalence and its 95%CI for each study were first calculated. We then meta-analyzed the point estimate of pooled ratio and the corresponding 95%CI \[[@CR23], [@CR24]\].

In all analyses, Cochran's Q test (significance level at *P \<* 0.10) and I^2^ statistics were applied to measure the heterogeneity \[[@CR25]\]. The I^2^ statistics is a quantitative measure of inconsistency across studies, with values of 25, 50 and 75% corresponding to low, moderate, and high degrees of heterogeneity, respectively \[[@CR26]\]. In the absence of observed heterogeneity between studies, the fixed effects model should be used for the data analysis; otherwise, the random effects model should be selected \[[@CR27], [@CR28]\]. We conducted subgroup analyses stratified by the endemic level or the type of targeted villages, or the number of slides used per stool, to evaluate the influence of these factors on outcomes.

Potential publication bias of studies was assessed with both Begg rank correlation test and Egger linear regression test \[[@CR29], [@CR30]\]. To test the robustness of the pooled ratio, we conducted a sensitivity analysis by omitting one study or publication at a time, and each time we calculated the pooled estimate for the remaining ones \[[@CR31]\].

Extracted data were entered into Microsoft Office Excel 2013 and all statistical analyses were performed with Stata 14.0. *P*\<0.05 was considered statistically significant, except where otherwise specified. All statistical tests were two-sided. The PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) statement was used as a guide in this paper \[[@CR32]\].

Results {#Sec8}
=======

Literature search {#Sec9}
-----------------

Figure [1](#Fig1){ref-type="fig"} contains a flow chart that describes search results and selection strategy for the studies included in this meta-analysis. We retrieved 471 published articles through five databases, of which 192 articles were excluded when taking duplication into consideration. After the initial screening of titles and abstracts, a further 216 articles were excluded. Consequently, we identified 63 potentially relevant publications for full-text review, of which 40 articles were excluded according to the inclusion criteria. Finally, a total of 23 articles were enrolled in this meta-analysis, with 11 articles about IHA \[[@CR33]--[@CR44]\], six about ELISA \[[@CR45]--[@CR50]\] and six about both IHA and ELISA \[[@CR51]--[@CR55]\].Fig. 1Flow chart of study selection

Study characteristics {#Sec10}
---------------------

Table [1](#Tab1){ref-type="table"} and Table [2](#Tab2){ref-type="table"} show the characteristics of the final 23 publications, which covered six provinces, namely Jiangsu, Anhui, Hunan, Hubei, Jiangxi and Yunnan provinces. The years of the studies performed and published ranged from 1990 to 2012 and from 1992 to 2015, respectively. The number of participants ranged from 101 to 1956 with IHA, 68 to 1024 with ELISA and 68 to 1956 with Kato-Katz.Table 1Characteristics of the eligible studies with IHA and the Kato-Katz methodAuthor, yearPeriod of studyLocationEndemic levelType of endemic areaFecal slides per stoolStudy groupNo. of seropositive with IHANo. total examined with IHANo. of fecal positiveNo. total examined with Kato-KatzPrevalence ratioWu,1992 \[[@CR51]\]1990--1991Gaojia village in Duchang County, Jiangxihigh (prevalence rate: 64.4% before treatment; 54.5% after treatment)ML^a^2before treatment110125331253.33after treatment102125312534.00Guan,1999 \[[@CR33]\]1997Zhongjiang village in Baimasi Town, Hubeihigh (20--30%)PW^b^24427071937742.51Li,2002 \[[@CR34]\]Sanlian and Lianhe villages in Dangtu County, Anhuilow (2.23%)ML349616156163.27Xiao,2005 \[[@CR36]\]2003Dongliang (village A) in Wuhu City, Puxi (village B) in Lanling County, Anhuilow (village A: \<2%)\
high (village B: 15%)PW3Dongliang43501250121.50Puxi240625666253.64Jin,2005 \[[@CR35]\]2003Chengde, Guanghui,Tiehu, Xianjin,Nanjiang and Xuguang villages in Tongling County, Anhuihigh (Chengde and Guanghui: \>10%)\
middle (Tiehu and Xianjin: 5--10%)\
low (Nanjiang and Xuguang: 1--5%)ML3Chengde134309623092.16Guanghui156308543082.90Tiehu88307273073.26Xianjin79294612941.30Nanjiang34308603080.56Xuguang25305413050.61Bao,2006 \[[@CR37]\]2005Xitan, Tangnan, Hongtang, Pudong villages in Nanling County, Anhuihigh (Xitan, Tangnan: TypeIvillage)\
middle (Hongtang, Pudong: Type IIvillage)PW2TypeIvillage158693546932.93TypeIIvillage117620136209.00Xu,2007 \[[@CR52]\]2005Lianhu village in Poyang County,Chaipeng village in Duchang County,Fuyu village in Yugan County, Jiangxihigh (Lianhu: 12.0%)\
middle (Chaipeng: 6.2%; Fuyu: 8.0%)ML3Lianhu,IHA-A706873839619.36Chaipeng,IHA-A147243254019.70Fuyu,IHA-A181443325026.41Lianhu,IHA-B390873839615.17Chaipeng,IHA-B90243254015.94Fuyu,IHA-B145443325025.13Yu,2007 \[[@CR38]\]Zhonjiang village in Hubei; Zhuxi village in JiangxiPW (Zhonjiang)\
ML (Zhuxi)2Zhonjiang3645711887702.61Zhuxi2062891663561.53Zhou,2007 \[[@CR53]\]Village A in Jiangxi;\
Village B in Anhuihigh (Village A: \>10%)\
low (Village B: \<5%)3Village A528102413010244.06Village B288787367878.00Zhou,2008 \[[@CR40]\]2001--2006An administrative village in Jiangxi32001100345289009.322002165600346004.822003174600416004.262004187600526003.592005332785976772.952006169603526323.41He,2008 \[[@CR54]\]2004Fengyi village in Zongyang County; Linye village in Anqing City, AnhuimiddleML3Fengyi151807258076.04Linye25216221612.50Lin,2008 \[[@CR12]\]Xinhua village in Xingzi County, Jiangximiddle (TypeIvillage)ML6106633436332.47Zhong,2009 \[[@CR41]\]2008Yanhu village in Xinjian County, Jiangximiddle (5--10%)ML3112420264204.31Hu,2010 \[[@CR42]\]2001Changjiang village in Yueyang City, Hunanlow (3--5%)ML3124511205116.20Lin,2010 \[[@CR43]\]2009Villages in Huangzhou, Songzi and Xiaonan District, Hubeilow (Huangzhou: \<1%; Songzi: 1--5%)\
middle (Xiaonan: 5--10%)ML3Huangzhou559235921.67Songzi16612969129618.44Xiaonan25101210112.50Lin,2010 \[[@CR55]\]Caohui village in Xinjian County, Jingtou village in Duchang County, Xinhua village in Xingzi County, JiangxiML3Caohui,M4475883558838.64Caohui,M5503883558839.15Jingtou,M4465927739276.37Jingtou,M5476927739276.52Xinhua,M4350922409228.75Xinhua,M5358922409228.95Liu,2014 \[[@CR44]\]2011Yongle and Xinzhuang villages in Eryuan County, Yunnanlow (\<1%)HM^c^3Yongle29319566195650.00Xinzhuang58778117785.36^a^Marshlands and lakes region^b^Plains with water networks^c^Hilly and mountainous regionTable 2Characteristics of the eligible studies with ELISA and the Kato-Katz methodAuthor, yearPeriod of studyLocationEndemic levelType of endemic areaType of ELISAFecal slides per stoolStudy groupNo. of seropositive with ELISANo. total examined with ELISANo. of fecal positiveNo. total examined with Kato-KatzPrevalence ratioWu,1992 \[[@CR51]\]1990--1991Gaojiao village in Duchang County, Jiangxihigh (prevalence rate: 64.4% before treatment; 54.5% after treatment)ML^a^McAb-Dot -ELISA2before treatment55125331251.67after treatment2112531257.00Huang,1994\[[@CR45]\]1990--1991Lianshi,Xingou,Yangjiayuan,third and fifth group of Zhaonao villages in Qianjiang City, Hubeilow (Lianshi: \<5%)\
middle (Xingou: 10%)\
high (Yangjiayuan and Zhaonao: 30%)MLDot-ELISA3Lianshi3688680.38Xingou157923790.65Yangjiayuan188524850.75Zhaonao III246824681.00Zhaonao IV46109151093.07Song,2003 \[[@CR46]\]2002Tanzhu village in Gaozi Town, JiangsulowMLSEA-ELISA38546394639.44Bao,2006 \[[@CR37]\]2005Xitan, Tangnan, Hongtang, Pudong four villages in Nanling County, Anhuihigh (Xitan, Tangnan: TypeIvillage)\
middle (Hongtang, Pudong: Type IIvillage)PW^b^SEA-ELISA2GradeItype village70324546932.77GradeIItype village713031362011.18He,2007Shujie village in Weishan County,YunnanhighHM^c^SEA-ELISA34235081205083.53Chen,20072005Three villages in Eryuan County,Yunnanlow, middle and high endemic village respectivelyHMSEA-ELISA4low epidemic22107210711.00middle endemic6712871289.57high epidemic67116611611.17Xu,20072005Lianhu village in Poyang County,Chaipeng vliiage in Duchang County,Fuyu village in Yugan County, Jiangxihigh (Lianhu: 12.0%)\
middle (Chaipeng: 6.2%; Fuyu: 8.0%)MLF-ELISA3Lianhu446873839615.92Chaipeng130243254018.58Fuyu183443325026.48Zhou,2007Village A in Jiangxi; Village B in Anhuihigh (Village A: \>10%)\
low (Village B: \<5%)SEA-ELISA3Village A682102413010245.25Village B5037873678713.97He,20082004Linye village in Anqing City, AnhuimiddleMLSEA-ELISA3Linye27216221613.50Lin,2010Caohui village in Xinjian County,Jingtou vliiage in Duchang County,Xinhua village in Xingzi County, JiangxiMLSEA-ELISA3Caohui,M3504883558839.16Jingtou,M3358927739274.90Xinhua,M3355922409228.88Yu,2011Village A in JiangxiSEA-ELISA380333133336.15She,20152012Dahekou village in Donggou Town, Jiangsulow (reach transmission control status in 2009)MLSEA-ELISA31958325839.50^a^Marshlands and lakes region^b^Plains with water networks^c^Hilly and mountainous region

Main analysis {#Sec11}
-------------

As seen in Fig. [2](#Fig2){ref-type="fig"}, the prevalence ratio of IHA to Kato-Katz varied from 0.57 to 48.83, with substantial heterogeneity among studies (χ^2^ = 713.34, *P* \< 0.001; I^2^ = 93.7%). The prevalence ratio of ELISA to Kato-Katz ranged from 0.38 to 13.97, with substantial heterogeneity among studies (χ^2^ = 266.77, *P* \< 0.001; I^2^ = 91.0%). See Fig. [3](#Fig3){ref-type="fig"}. The pooled prevalence ratio was 4.72 (95%CI: 3.87\~ 5.76) for IHA to Kato-Katz and 4.65 (95%CI: 3.50\~ 6.17) for ELISA to Kato-Katz when calculated with the random-effects model.Fig. 2Forest plot of prevalence ratio for IHA to Kato-Katz with random-effects analysesFig. 3Forest plot of prevalence ratio for ELISA to Kato-Katz with random-effects analyses

Subgroup analyses {#Sec12}
-----------------

Table [3](#Tab3){ref-type="table"} shows the results of subgroup analyses stratified by the endemic level, the number of slides used per stool sample and the type of endemic area. Due to the high heterogeneity among studies within most subgroups, pooled ratios for each subgroup were calculated using the random-effects model. In terms of endemic levels, the pooled ratio of IHA to Kato-Katz showed the highest estimate in the middle endemic areas (RR: 4.99, 95%CI: 3.39\~ 7.34) and the lowest in high endemic (RR: 4.05, 95%CI: 2.93\~ 5.60). A downtrend was observed in the pooled ratios of ELISA to Kato-Katz (Low endemic areas: 6.06, 95%CI: 2.22\~ 16.58; Middle: 5.92, 95%CI: 2.74\~ 12.80; High: 3.06, 95%CI: 2.09\~ 4.50). In terms of the number of slides per stool in Kato-Katz, the highest ratio of IHA to Kato-Katz (PRR: 5.03, 95%CI: 4.05\~ 6.25) was obtained for three slides per stool specimen, whereas the lowest ratio (PRR: 2.47, 95%CI: 1.70\~ 3.57) was obtained for over four slides per stool. The ratio of ELISA to Kato-Katz increased with the number of slides used (2 slides: 4.11, 95%CI: 1.76\~ 9.61; 3 slides: 4.41, 95%CI: 3.20\~ 6.08; ≥4 slides: 10.38, 95%CI: 5.97\~ 18.05).Table 3Pooled estimates of prevalence ratio by potential influential factors with meta-analysisGroupIHA to KKELISA to KKNo. of papersNo. of studiesPrevalence ratio (95%CI)*P* ~heterogeneity~I^2^(%)No. of papersNo. of studiesPrevalence ratio (95%CI)*P* ~heterogeneity~I^2^(%)Total17464.72(3.87,5.76)0.00093.712254.65(3.50,6.17)0.00091.0Endemic level Low7104.89(1.92,12.43)0.00095.9556.06(2.22,16.58)0.00084.2 Middle7124.99(3.39,7.34)0.00086.6565.92(2.74,12.80)0.00089.0 High7104.05(2.93,5.60)0.00091.57103.06(2.09,4.50)0.00088.7Number of slides per stool 2473.45(2.37,5.03)0.00089.2244.11(1.76,9.61)0.00088.2 312385.03(4.05,6.25)0.00091.79184.41(3.20,6.08)0.00090.6  ≥ 4112.47(1.70,3.57)----1310.38(5.97,18.05)0.9650.0Type of endemic area Marshlands and lakes region11304.60(3.45,6.14)0.00093.87163.73(2.48,5.60)0.00090.7 Plains with water networks463.64(2.64,5.00)0.00082.2125.45(1.37,21.66)0.00093.3 Hilly and mountainous regions1215.86(1.47,171.60)0.00095.2247.20(3.33,15.57)0.00576.5

Subgroup analyses showed the highest pooled estimates in the hilly and mountainous regions (IHA to KK: 15.86, 95%CI: 1.47\~ 171.60; ELISA to KK: 7.20, 95%CI: 3.33\~ 15.57). The lowest was in plains with water network areas for IHA to Kato-Katz (RR: 3.64, 95%CI: 2.64\~ 5.00) and in marshlands and lake regions for ELISA to Kato-Katz (RR: 3.73, 95%CI: 2.48\~ 5.60).

Sensitivity analyses {#Sec13}
--------------------

Sensitivity analyses presented that all single-study-omitted and single-paper-omitted estimates were within the 95%CIs of their respective overall ratios except one paper (see Additional files [2](#MOESM2){ref-type="media"}, [3](#MOESM3){ref-type="media"}, [4](#MOESM4){ref-type="media"} and [5](#MOESM5){ref-type="media"}). This suggested that the pooled ratios were not substantially modified by any single study, or by any single paper except Huang et al. \[[@CR45]\]. The stability of such results validated the rationality and reliability of our analyses.

Publication bias {#Sec14}
----------------

There was no evidence of publication bias, as suggested by Begg rank correlation test (z = 1.18, *P* = 0.237 for IHA and z = 0.54, *P* = 0.591 for ELISA) and Egger linear regression test (the bias coefficients b = 2.64, 95%CI: -0.17\~ 5.46, *t* = 1.89, *P* = 0.065 for IHA and b = − 0.69, 95%CI: -3.45\~ 2.07, *t* = − 0.52, *P* = 0.610 for ELISA).

Discussion {#Sec15}
==========

Egg-negative but worm-positive schistosomiasis may be a potential threat for achieving the goal of schistosomiasis elimination \[[@CR22]\]. Therefore, accurate detection of *Schistosoma japonicum* infections in humans plays a crucial role in the process of control and treatment \[[@CR56]\]. There were also a number of other publications exploring the differences of parasitological and immunological diagnostic assays in field situations in China, but in those research Kato-Katz was only applied to human individuals after they had been tested positive with immunodiagnostic method, not qualifing the criteria of inclusion in our research \[[@CR13], [@CR56]--[@CR69]\]. We here included only 23 articles in the current meta-analysis \[[@CR33]--[@CR55]\]. The findings of this meta-analysis showed that the prevalence by IHA or ELISA is 4- to 5-fold higher than the prevalence by Kato-Katz, which indicated that Kato-Katz clearly underestimated the prevalence of *S. japonicum* in China. Subgroup analyses suggested that the ratio of the serological to the egg-positive prevalence decreased with the endemic levels. A highest prevalence ratio was obtained when the number of slides per stool was three and was in the hilly and mountainous regions.

Compared with the egg-determined prevalence by a single stool examination, the worm-determined prevalence by IHA or ELISA were about 4--5 times higher, indicating the existence of substantial inconsistencies between two types of examinantions. Multiple stool examinations with Kato-Katz can increase the positive rate and obtain more accurate results, but it is impractical in the field \[[@CR10], [@CR70]\]. The Kato-Katz test is most widely used and the misdiagnosis or even absence of eggs can be quite common in the field, especially in low endemic regions \[[@CR40], [@CR71], [@CR72]\]. Therefore, it is obvious that the positive prevalence with one stool examination is much lower than with IHA and ELISA.

Although the overall seroprevalence was about 4- to 5-fold higher than the pooled coprological prevalence, the prevalence ratio per study varied from 0.57 to 48.83 for IHA to KK and ranged from 0.38 to 13.97 for ELISA to KK. Several explanations could account for the substantial heterogeneity among studies. First, 14 eligible publications provided more than one group of studies and these studies could not be combined directly \[[@CR35]--[@CR38], [@CR40], [@CR43]--[@CR45], [@CR47], [@CR51]--[@CR55]\]. Second, study regions and periods varied in epidemiological settings, such as types of endemic areas, recorded prevalence level and transmission intensity. Third, different diagnostic reagents and the number of slides per stool may also cause the discrepancies. Fourth, sample sizes among included studies differed greatly, ranging from 68 to 1956. Finally, there are several cases which should be noted. The prevalence ratio of IHA to Kato-Katz was 50 in Yongle Village \[[@CR44]\] and 34 after mass chemotherapy in Gaojia Village \[[@CR51]\], which were much higher than the others. The infection rate in Yongle village was very low (0.8%) with Kato-Katz, leading to an underestimation of true infections \[[@CR44]\]. In Gaojia village after 3 months of treatment the number of infections with Kato-Katz may decrease sharply but the antigen level of IHA in serum should be still very high, thus resulting in the high ratio \[[@CR51]\]. When comparing Kato-Katz and ELISA, most articles applied the routine ELISA method to detect the antibodies, whereas two articles \[[@CR45], [@CR51]\] applied the Dot-ELISA method to detect the CAg in serum. However, the results between two papers were controversial. All these factors may lead to such differences among these studies.

Subgroup analyses, based on limited numbers of papers, revealed that the prevalence ratio decreased with the increase level of endemic degrees, although the ratio of IHA to ELISA was slightly higher in middle endemic villages than in low endemic villages. This may be mainly related to a high false negative rate for egg detection in stool in low endemic areas, particularly after widespread chemotherapy \[[@CR73], [@CR74]\].

Repeated and multiple stool examinations can provide more accurate results, but it is quite time-consuming and strenuous in the filed \[[@CR10], [@CR70]\]. As different stool specimens can not be compared directly, we only included articles in which a single stool examination was carried out. The findings showed that the highest prevalence ratio of IHA to Kato-Katz was 5.03 (95%CI: 4.05\~ 6.25) with three slides per stool, and of ELISA to Kato-Katz was 10.38 (95%CI: 5.97\~ 18.05) with ≥4 slides per stool. However, it is noted that only one article \[[@CR47]\] provided data of fecal examinations with equal or more than four slides per stool specimen. So the uptrend of the prevalence ratio of ELISA to Kato-Katz with the increase of numbers of slides per stool was suspected. A relative high ratio was observed when examined with Kato-Katz with three slides per stool in our meta-analysis. Indeed, Lin et al. \[[@CR75]\] once reported that the rates of underestimation with three slides per stool specimen could reach 40.98\~ 50.80%, especially in low endemic areas.

There were only three articles involved in hilly and mountainous regions \[[@CR44], [@CR47], [@CR48]\] with one on IHA to Kato-Katz and two on ELISA to Kato-Katz. We believed that the patients in Yongle village could, because of the low infection rate by the Kato-Katz method, be largely missed \[[@CR44]\]. Overall, the current meta-analysis showed the highest prevalence ratio in hilly and mountainous regions. This may provide support for further schistosomiasis control among different endemic areas.

However, there are some disadvantages for immunological tests. The main one is the relatively high false-positive rate, as they can not discriminate active infection from past infection \[[@CR76]--[@CR78]\]. The false-positive rates of IHA and ELISA were reported to be 0.062 to 0.643 and 0.157 to 0.755, respectively \[[@CR17]\]. In this meta-analysis, two articles \[[@CR45], [@CR51]\] applied the Dot-ELISA method to detect the CAg in serum. The negative reversal rate of egg-positive patients was 66.7% with McAb-Dot-ELISA and 0 with IHA after 3 months of treatment \[[@CR51]\]. However, research also showed that most patients turned negative with IHA after effective and periodical treatment for 3 years or more \[[@CR16]\]. After one to 2 years of treatment, the negative reversal rate was nearly 60% in the ELISA assay, and most patients turned negative in the Dot-ELISA test \[[@CR16]\]. Overall, the Dot-ELISA assay appears to be more efficient than the routine IHA or ELISA. The false-positive rate of immunological tests is also a limitation of this paper, partly leading to an inflated prevalence ratio of IHA to Kato-Katz or of ELISA to Kato-Katz.

Conclusions {#Sec16}
===========

In summary, the worm-determined prevalence by IHA or ELISA was about 4- to 5-fold higher than the egg-determined prevalence by Kato-Katz, which implied that the Kato-Katz method may largely underestimate the infection prevalence of *S. japonicum* in the field. The degree of underestimation became worse when being examined by Kato-Katz with three slides per stool, especially in low endemic areas or in hilly and mountainous regions. Such significant difference between the fecal and the serological examinations may lead to the existence of a sizable population of "egg-negative but worm-positive schistosomiasis". Therefore, more attention should be paid to those infected humans with the aim of final elimination of *S. japonicum* in China.
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